AEGiS-PRn: Gates Foundation, BIO Global Health Forum Features International Health Experts PRNewswireImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to PRNewswire main menu
DonateNow


Gates Foundation, BIO Global Health Forum Features International Health Experts

PRNewswire - November 5, 2002


WASHINGTON, Nov. 5 /PRNewswire/ -- The Biotechnology Industry Organization (BIO) today announced that Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and David L. Heymann, MD, executive director of communicable diseases for the World Health Organization (WHO), will address BIO's Partnering for Global Health Forum 2002. Hosted in conjunction with the Bill & Melinda Gates Foundation, the Dec. 3-5 forum will bring together biotech industry leaders, potential funders and international health experts to explore how biotechnology can improve health in the developing world.

As director of NIAID, a division of the National Institutes of Health (NIH), Fauci oversees basic and applied research to prevent, diagnose and treat infectious and immune-mediated illnesses, including HIV/AIDS, tuberculosis, malaria and autoimmune disorders. Fauci has made numerous scientific contributions to understanding how immunosuppressive agents, such as HIV, modulate the human immune response.

Heymann is responsible for the surveillance and control of communicable diseases, such as tuberculosis, leprosy, hepatitis, malaria, AIDS/HIV, and meningitis at WHO. Prior to joining WHO, Heymann spent 13 years in sub-Saharan Africa on assignment from the Centers for Disease Control and Prevention (CDC) with a special emphasis on the surveillance and control of African haemorrhagic fevers, pox viruses, malaria and Ebola. Heymann also spent two years in India as a medical officer in the WHO Smallpox Eradication Programme.

For more information on BIO's Partnering for Global Health Forum, please visit http://www.bio.org. Press registration is now available and is complimentary for credentialed members of the news media. Press releases, conference updates and registration information are posted in the "Media" section of the conference Web site.

BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.

SOURCE Biotechnology Industry Organization

Web Site: http://www.bio.org


021105
PR021109


Copyright © 2002 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019  http://www.prnewswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .